Two genes identified in our study (ITPKB, CCDC12) demonstrated significant stratification of low and high risk AML patient survival (P = 0.03 CI = 55), with higher significance than RUNX1 status alone (P = 0.08 CI=52). The gene discussed is RUNX1; the disease is acute myeloid leukemia.